Darbepoetin alfa is cost effective compared to epoetin alfa for treatment of anemia in cancer patients receiving chemotherapy.

被引：0
|
作者：
Glaspy, JA
Tchekmedyian, NS
Gupta, S
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA 90024 USA
[2] Pacific Shores Med Grp, Long Beach, CA USA
[3] Amgen Inc, Med Affairs Pharmacoecon, Thousand Oaks, CA 91320 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3447
引用
下载
收藏
页码：874A / 875A
页数：2
相关论文
共 50 条
  • [31] Cost-effectiveness of once weekly epoetin alfa and darbepoetin alfa in treating chemotherapy-induced anemia.
    Ben-Hamadi, R
    Duh, MS
    Henchler, A
    McKenzie, S
    Fastenau, J
    Piech, CT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 551S - 551S
  • [32] Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice
    Patton, J
    Reeves, T
    Wallace, J
    ONCOLOGIST, 2004, 9 (04): : 451 - 458
  • [33] Darbepoetin alfa in chemotherapy - Induced anemia treatment
    Grangeia, Luis
    da Cunha, Marinho
    Baptista, Ana
    Aroso, Manuela
    Moura, Antonio
    Mesquita, Teresa
    ANNALS OF ONCOLOGY, 2006, 17 : 303 - 304
  • [34] Treatment of anemia with epoetin alfa 80,000 U QW in cancer patients receiving chemotherapy
    Tarabay, G
    Braly, P
    Baker, JJ
    Williams, D
    Waltzman, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 780S - 780S
  • [35] Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness
    Voils, Stacy A.
    Harpe, Spencer H.
    Brophy, Gretchen M.
    PHARMACOTHERAPY, 2007, 27 (04): : 535 - 541
  • [36] COST-EFFECTIVENESS MODELLING OF EPOETIN ALFA AND DARBEPOETIN ALFA IN THE TREATMENT OF CHEMOTHERAPY-RELATED ANAEMIA IN SWEDEN
    Liwing, J.
    Nasman, P.
    Kernell, H.
    Gagnon, D. D.
    Wu, Y.
    VALUE IN HEALTH, 2010, 13 (03) : A38 - A38
  • [37] Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in Sweden: Comparative analysis of drug utilization, costs, and hematologic response
    Ulf Persson
    Sixten Borg
    Sandra Jansson
    Tor Ekman
    Lars Franksson
    Signe Friesland
    Anna-Maria Larsson
    Advances in Therapy, 2005, 22 : 208 - 224
  • [38] Haemoglobin fluctuations in haemodialysis patients receiving intravenous epoetin alfa or intravenous darbepoetin alfa
    Walker, R.
    Pussell, B. A.
    VALUE IN HEALTH, 2007, 10 (03) : A103 - A103
  • [39] Cost of managing anemia with and without prophylactic epoetin alfa therapy in breast cancer patients receiving combination chemotherapy
    Meadowcroft, AM
    Gilbert, CJ
    Maravich-May, D
    Hayward, SL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (18) : 1898 - 1902
  • [40] Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in Sweden: Comparative analysis of drug utilization, costs, and hematologic response
    Persson, U
    Borg, S
    Jansson, S
    Ekman, T
    Franksson, L
    Friesland, S
    Larsson, AM
    ADVANCES IN THERAPY, 2005, 22 (03) : 208 - 224
12345